China (CN) Breast Lift

Breast Lift Related Terms:
Breast Lift In China CN, China Body Procedures, China Boobs Job, China Boobs Lift, China Bosom Lift, China Breast, China Breast Augmentation, China Breast Enlargement, China Breast Enlargement, China Breast Implants, China Breast Lift, China Breast Lift Crescent Incision, China Breast Lift Doughnut Incision, China Breast Lift T Incision, China Breast Lift Vertical Incision, China Breast Procedures, China Breast Up Lift, China Capsular Contracture, China Chest, China Cosmetic Surgery, China Mastopexy, China Non Surgical Breast Lift, China Plastic Surgery, China Saline Breast Implants Areola Incision, China Saline Breast Implants Armpit Incision, China Saline Breast Implants Under The Breast Incision, China Silicone Breast Implants Areola Incision, China Silicone Breast Implants Armpit Incision, China Silicone Breast Implants Under The Breast Incision

Breast Lift in China section, includes general infrmation about Breast Lift Procedure, Breast Lift China Local News, Breast Lift China Surgeon Locator and other Breast Lift related material.

China breast lift - Tip of the day:

Post-surgery Tips
After Breast Lift in China(CN), an augmented breast requires extra support thus a sports bra or bandage is required, with continuous usage for about a month. Shower after 24 hours from surgery. You will need to stay in hospital 2-7 days after the surgery. During such time you may feel pain and weakness for a week or two. Complete recovery may take up to 6 weeks, depending on the surgery.

Breast Lift Procedure

A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).

China breast lift - News update:
Meta-analysis of data from controlled trials has found that in postmenopausal women with breast cancer, aromatase-inhibitor treatment is associated with a statistically significant but small increase in risk of cardiovascular events. The authors note that the aromatase inhibitors are more effective than tamoxifen in the treatment of breast cancer; however reports suggest that they may be associated with a higher cardiovascular risk. This analysis aimed to clarify the risk to benefit balance for these drugs. The authors carried out a comprehensive search, mostly using specialist sources, for long-term (five year) randomised controlled trials of aromatase inhibitors against tamoxifen after surgery in women with breast cancer where data on cardiovascular adverse events were reported. From this data, they derived the event risk-ratios and absolute event rates with the two drug groups. Primary outcome was grade 3 and 4 cardiovascular adverse events. The initial search located ten potentially relevant trials of which 7 (n=19,818) were eligible for the analysis. All had been published in full, and three had subsequent updates. On the primary outcome, there was an increased risk of 0.52% in the aromatase inhibitor arm compared to the tamoxifen arm; a risk ratio of 1.31 (95% CI, 1.07 to 1.60; P =0.007). Thromboembolic events were a secondary outcome, and these were less likely than in the tamoxifen arm (RR, 0.53; 95% CI, 0.42 to 0.65; P <0.0001). The authors conclude that treatment with aromatase inhibitors is associated with a small increase in risk of cardiovascular adverse events - while this is statistically significant, the number needed to harm is around 160 to 180. It may be balanced by a reduced risk of thromboembolic events. More...